Drug developers have successfully tackled general anxiety with a number of innovations. But social anxiety disorder, which can trigger debilitating fear, self-consciousness or nervousness during ...

The FDA recently OK'd Gilead's novel HIV combo med, and cell therapy deals have fallen dramatically in two years.

More than 25 years after it was declared eliminated, measles has surged back. But drug R&D is still in early stages and up ...

Wall Street analysts believe that a more cautious approach to manufacturing, study enrollment and side effect management ...

Gilead’s new “Up to Date” campaign uses humor and dating scenarios to reach Black communities amid persistent gaps in HIV ...

Dealmaking in the autoimmune space is thriving as biotechs chase new targets with the potential to treat more conditions.

Chinese clinical trials have become synonymous with speed and savings, but questions have surfaced about the price of those advantages. Reports surfaced over the summer of three deaths in Chinese ...

Late-stage drugs in pancreatic cancer, multiple myeloma and Alzheimer’s could pair treatment advances with major commercial ...

CAR-T’s commercial challenge isn’t making bigger batches. It’s making thousands of patient-specific manufacturing runs behave ...

MASLD illustrates the shifting calculus of early intervention trials. As the leading chronic liver disease, affecting roughly ...